SCHEMBL7773349

SCHEMBL7773349

NC(CN1CCN(c2ccccc2)CC1)c1nc2ccccc2s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 6/20 0.50
DRD2 P14416 6/20 0.50
DRD3 P35462 5/20 0.50
DRD4 P21917 2/20 0.50
HTR2A P28223 6/20 0.49
SLC6A4 P31645 6/20 0.49
HTR7 P34969 5/20 0.49
HTR2C P28335 4/20 0.49
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CYP1A2 P05177 1/20 0.46
POLB P06746 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
DRD1 P21728 2/20 0.46
ALDH1A1 P00352 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL7773436 0.91 DRD2 (0.51) HTR1ADRD2DRD3DRD4HTR2A
SCHEMBL7773386 0.91 SLC27A1 (0.54) HTR1ADRD2DRD3DRD4HTR2A
SCHEMBL7776881 0.91 HTR2A (0.58) HTR1ADRD2DRD3DRD4HTR2A
Hydrochloric Acid SCHEMBL7775345 0.90 SLC27A1 (0.53) HTR1ADRD2DRD3DRD4HTR2A
Hydrochloric Acid SCHEMBL7775443 0.90 HTR2A (0.57) HTR1ADRD2DRD3DRD4HTR2A
SCHEMBL7773411 0.85 DRD2 (0.57) HTR1ADRD2DRD3DRD4HTR2A
Bromide SCHEMBL7773488 0.85 NPC1 (0.43) SLC6A4HTR7NPC1RAB9AMEN1
SCHEMBL7775390 0.83 DRD4 (0.58) HTR1ADRD2DRD3DRD4HTR2A
SCHEMBL7773395 0.82 SIGMAR1 (0.46) HTR1ADRD2DRD3DRD4HTR2A
SCHEMBL7773492 0.82 DRD2 (0.45) HTR1ADRD2DRD3DRD4HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1325397-A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands NEUROGEN CORP (US) 2001-12-05 CN claimed
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP claimed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO claimed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO claimed
CN-1325397-A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands NEUROGEN CORP (US) 2001-12-05 CN disclosed
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP disclosed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO disclosed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO disclosed